ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,118.71
0.00%
US Tech 100
21,277.60
-0.13%
다우존스 지수
44,565.07
0.00%
Bitcoin
105,170.24
1.16%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Bicycle Therapeutics PLC (BCYC)

  7. Bicycle Therapeutics PLC (BCYC) 뉴스

BCYC

Bicycle Therapeutics (BCYC)

Bicycle Therapeutics PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BCYC
일자시간출처헤드라인심볼기업
2025/01/1406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/1321:00Business WireBicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and MilestonesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0921:00Business WireBicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0709:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0702:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0406:05Business WireBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0306:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0306:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0306:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0306:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0306:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2025/01/0306:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2024/12/2005:47Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCYCBicycle Therapeutics PLC
2024/12/1323:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
2024/12/1308:30Business WireBicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene AmplificationNASDAQ:BCYCBicycle Therapeutics PLC
2024/12/1021:00Business WireBicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology ExpertsNASDAQ:BCYCBicycle Therapeutics PLC
2024/12/0306:05Business WireBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCYCBicycle Therapeutics PLC
2024/11/2607:30Business WireBicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program UpdateNASDAQ:BCYCBicycle Therapeutics PLC
2024/11/1506:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
2024/11/1409:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
2024/11/1223:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
 검색 관련기사 보기:NASDAQ:BCYC

최근 히스토리

USOTC
BNPQY
BNP Paribas (QX)
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
NYSE
AXP
American Express
NYSE
BAC
Bank of America
NASDAQ
GOOGL
Alphabet
COIN
AVAXUSD
Avalanche
COIN
SOLUSD
Solana
CCOM
US500
US 500
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
FX
USDGBP
US Dollar vs Sterling
USOTC
BASFY
BASF (QX)
AMEX
XLV
Health Care Select Sector
NASDAQ
NVDA
NVIDIA
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유